A Look At GeneDx Holdings (WGS) Valuation After New CMO Appointment And Record Rare Disease Genomics Year [Yahoo! Finance]
GeneDx Holdings Corp. - Class A (WGS)
Company Research
Source: Yahoo! Finance
See our latest analysis for GeneDx Holdings. The appointment of Dr. Genen and the strong research year arrive as the stock trades at US$135.8, with a 1-day share price return of 3.27% and a 7-day share price return of 6.09%. Despite a 14.57% decline in the 30-day share price return, the 90-day share price return of 10.69% and a 1-year total shareholder return of 39.94% point to momentum that has built over time. The very large 3-year total shareholder return contrasts with a weaker 5-year total shareholder return. If this kind of genomics story has your attention, it could be a good moment to widen your research and scan healthcare stocks for other healthcare names catching interest. With the shares at US$135.8 and trading at a discount to analyst price targets and some intrinsic estimates, the key question is whether this reflects mispriced potential or a market that has already factored in expectations of future growth. Compared with the US$135.8 last close, the most follow
Show less
Read more
Impact Snapshot
Event Time:
WGS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WGS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WGS alerts
High impacting GeneDx Holdings Corp. - Class A news events
Weekly update
A roundup of the hottest topics
WGS
News
- Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their RightsBusiness Wire
- GeneDx: Fundamentals Intact Though Q4 Results Pause Near Term Momentum [Seeking Alpha]Seeking Alpha
- GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance [Yahoo! Finance]Yahoo! Finance
- GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 GuidanceBusiness Wire
- GeneDx and Komodo Health Partner to Build the World’s Most Complete Longitudinal Rare Disease DatasetBusiness Wire
WGS
Earnings
- 10/28/25 - Beat
WGS
Sec Filings
- 1/12/26 - Form 8-K
- 12/18/25 - Form 4
- 12/18/25 - Form 4
- WGS's page on the SEC website